|
|
 |
Trial Information
Summary: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab on Prolonging Bone Metastasis-Free Survival in Men with Hormone Refractory Prostate Cancer
Is your PSA rising despite hormone therapy for your prostate
cancer?
|
Contact:
Staten Island Urological Research, P.C.
1800 Clove Road
Staten Island, NY 10304
Telephone: 718-720-6040
Fax: 718-720-6523
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 6:30:08 AM
|
 |
|